Asthma: Difference between revisions
Jump to navigation
Jump to search
imported>Derek Harkness m (Remove wikipedia {{med-stub}} template) |
imported>Subpagination Bot m (Add {{subpages}} and remove any categories (details)) |
||
| Line 1: | Line 1: | ||
{{subpages}} | |||
==Definition== | ==Definition== | ||
| Line 16: | Line 18: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 21:52, 24 September 2007
Definition
Epidemiology
Etiology
Pathophysiology
Diagnosis
Prognosis
Treatment
A systematic review by the Cochrane Collaboration found that monitoring sputum eosinophils can guide treatment[1] The review identified three randomized controlled trials that found that benefit from adjusting anti-inflammatory medications to maintain less than 2 to 8% eosinophils in sputum.
References
- ↑ Petsky H, Kynaston J, Turner C, et al (2007). "Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults". Cochrane database of systematic reviews (Online) (2): CD005603. DOI:10.1002/14651858.CD005603.pub2. PMID 17443604. PMID 17443604. Research Blogging.